含氮亲核试剂在2-甲磺酰基-5-(3,4,5-三甲氧基苯基)-1,3,4-噁二唑环上取代反应的研究

2,5—二取代—l,3,4—噁二唑化合物具有消炎,抗菌,调节植物生长,杀虫门等广泛的生物活性。作者曾研究了取代胺在2—甲磺酰基—5—(2—苯基—4—喹啉基)—1,3,4—噁二唑化合物环2—位上的亲核加成消去反应,制得了一系列新的2—取代基—5—(2—苯基—4—喹啉基)—1,3,4—噁二唑衍生物,并发现它们具有一定的抗菌活性。在此基础上,我们又研究了含氮亲核试剂在 2—甲磺酰基—5—(3,4,5—三甲氧基苯基)—1,3,4,—噁二唑环2—位上的亲核加成消去反应,制得一系列新的2—取代基—5—(3,4,5—三甲氧基苯基)—1,3,4—噁二唑衍生物。作者用3,4,5—三甲氧基苯甲酰肼在KOH催化下与CS_2反应得到2—巯基—5—(3,4,5—三甲氧基苯基)—l,3,4—噁二唑1,1在NaOH溶液中与Me_2S0_4作用得到2—甲硫醚—5—(3,4,5—三甲氧基苯基)—1,3,4—噁二唑2,2在冰醋酸水溶     

2-芳氧基-5-苯基-1,3,4-恶二唑类化合物的合成

通过芳氧基负离子在2-甲磺酰基-5-1,3,4-恶二唑上的亲核取代反应制得2-芳氧基-5-苯基-1,3,4-恶二唑.所有化合物的结构经元素分析,IR, ^1H NMR和MS确证.这些化合物表现出一定的抑制枯草芽孢杆菌繁殖的活性.     

2-芳氧基-5-苯基-1,3,4-噁二唑类化合物的合成

本文通过芳氧基负离子在2—甲磺酰基—苯基—1,3,4—噁二唑环2—位上的亲核取代反应制得9个新的2—芳氧基—5—苯基—l,3,4—噁二唑衍生物。所有化合物的结构经元素分析,IR,~1H NMR和MS确认。初步抗菌实验表明这些化合物具有一定的抑制枯草芽孢杆菌繁殖的活性。 2,5—二取代l,3,4—噁二唑衍生物具有广泛的生物活性,如抗菌,抗黄球菌,除草杀棉花牙虫等。Madhavan等曾通过芳胺在2— 甲磺酰基—5—芳基1,3,4—噁二唑环上的亲核取代反应,制得了2—芳氨基—5—芳基—l,3,4—噁二唑衍生物,我们也曾通过酰肼等亲核试剂在2—甲磺酰基—5—(3,4,5—三甲氧基苯基)—1,3,4—噁二唑环上的亲核取代反应,得到了2—取代酰肼基—5—(3,4,5—三甲氧基苯基)—l,3,4—噁二唑衍生物。在此基础上,我们拟通过Aro在2—甲磺酰基     

(3-苄基-4-芳酰基-1,2,4-三唑-5-基)(5-本基-1,3,4-噁二唑-2-基)硫醚的合成

通过3-苄基-4-芳酰基-1,2,4-三唑-5-巯基负离子在2-甲磺酰基-5-苯基-1,3,4-噁二唑环2-位上的亲核取代反应,制得13个新的(3-苄基-4-芳酰基-1,2,4-三唑-5-基)(5-苯基-1,3,4-噁二唑-2-基)硫醚衍生物.经元素分析、IR、~1H NMR和MS裂解碎片分析确认结构.初步观察了它们在0.01％浓度时对大肠杆菌繁殖的抑制作用.     

In(OTf)3催化下水相合成2-(3,4,5-三甲氧基苯基)-5-[(5-烷硫基-1,3,4-噁二唑-2-基)硫甲基]-1,3,4-噻二唑类衍生物

以2-巯基-5-(3,4,5-三甲氧基苯基)-1,3,4-噻二唑为原料,经醚化、酰肼化、闭环、硫醚化四步反应合成了10个2-(3,4,5-三甲氧基苯基)-5-[(5-烷硫基-1,3,4-噁二唑-2-基)硫甲基]- 1,3,4-噻二唑类衍生物。通过元素分析、IR、MS、1H NMR和 13C NMR对目标化合物进行了表征。采用In(OTf)3催化下40 oC水相合成目标化合物,具有反应条件温和、合成收率高、催化剂可循环使用等特点。     

1,3,4-噁二唑三氮烯衍生物的合成及生物活性测定

利用拼合原理,将具有生物活性的三氮烯结构与1,3,4-噁二唑结构相拼合,设计合成了11个未见报道的1,3,4-噁二唑三氮烯衍生物.所合成化合物经1H NMR,IR和HRMS得到表征.用四甲基偶氮唑盐(MTT)法法评价了该类化合物对胃癌细胞(MGC803)和前列腺癌细胞(PC-3)的抑制作用,结果显示化合物2-[4-(3,3-二甲基三氮烯-1-基)苯基]-5-(4-甲氧基苯基)-1,3,4-噁二唑(b4)、2-[4-(3,3-二甲基三氮烯-1-基)苯基]-5-(2-甲氧基苯基)-1,3,4-噁二唑(b9)、2-[4-(3,3-二甲基三氮烯-1-基)苯基]-5-(3,4-甲叉二氧基苯基)-1,3,4-噁二唑(b10)、2-[4-(3,3-二甲基三氮烯-1-基)苯基]-5-(吡啶-4-基)-1,3,4-噁二唑(b11)对前列腺癌细胞的抑制作用强于典型三氮烯药物达卡巴嗪(DTIC),其IC50值分别为74.145,87.790,87.327和104.875μmol/L,而对胃癌细胞则几乎没有抑制作用.采用微量肉汤稀释法测试了该类化合物对大肠埃希菌(E.coli.)和金黄葡萄球菌(S.aureus)的抑制作用,结果显示这类化合物对这两种细菌并没有表现出抑制作用.     

酰氨基硫脲及其相关杂环衍生物的研究II.1-[5-(α-萘)-2H-四唑-2-乙酰[-4-苯基氨基硫脲及其相关环衍生物的合成

本文合成了1-[5-(α-萘)-2-H-四唑2-乙酰]-4-苯基氨基硫脲5,以及由5衍生的环化产物3-[5-(α-萘)-2H-四唑2-甲撑]-4-苯基-1,2,4-三咪啉-5-硫酮6,2-苯胺基-5-[5-(α-萘)-2H-四唑-2-甲撑]-1,3,4-噻二唑7及2-苯胺基-5-[5-(α-萘)-2H-四唑-2-甲撑]-1,3,4-二唑8.它们的结构均通过元素分析,红外光谱,核磁共振及质谱鉴定.其药理实验正在进行中.初步实验表明,5及6对小麦生长有较强的促进作用.     

2-取代苯基-5-(3,4,5-三甲氧基苯基)-1,3,4-噁二唑衍生物的合成及生物活性研究

合成了10个2-取代苯基-5-(3,4,5-三甲氧基苯基)-1,3,4-噁二唑衍生物. 并经过元素分析, IR, ¹H NMR, ¹³C NMR对其结构进行了确认. 初步生物活性测试表明, 部分化合物具有一定抗癌活性.     

3-取代胺甲基-5-连三唑基-1, 3, 4-恶二唑-2-硫酮的合成

2-苯基-1,2,3-三唑-4-甲酰肼(1)在CS~2/KOH作用下环化得到5-(2-苯基-1,2,3-连三唑-4-基)-1,3,4-恶二唑-2-硫酮(2),2经Mannich反应合成得到标题化合物3-(取代胺甲基-5-(2-苯基-1,2,3-连三唑-4-基)-1,3,4-恶二唑-2-硫酮(3)。     

2-芳基-5-(2-苯基-4-喹啉基)-1,3,4- 二唑衍生物的合成及其相关性质的研究

本文选择淘汰的解热镇痛, 去风湿药物2-苯基-4-喹啉甲酸(辛可芬)制成芳酰基化合物, 然后用POCl3脱水, 得到一些新的2-芳基-5-(2-苯基-4-喹啉基)-1,3,4-恶二唑(2)。该化合物在医学、农药、染料、涂料, 高分子合成材料以及有机闪烁材料等方面有广泛用途。     

2－氯／2－甲磺酰基－5－（2－苯基－4－喹啉基）－1，3，4－噁二唑化合物的合成及其亲核取代的研究

借处理２－羟基－５－（２－苯基－４－喹啉基）－１，３，二唑同ＰＣｌ＿５／ＰＯＣｌ＿３之间的反应合成了２－氯－５－（２－苯基－４－喹啉基）－１，３，４－二唑（３）和通过２－基－５－（２－苯基－４－喹啉基）－１，３，４－二唑的甲基化，然后氧化制得２－甲磺酰基－５－（２－苯基－４－喹啉基）－１，３，４－二唑（６）．并分别研究了３和６同胺、叠氮及肼的反应，得到２，５－二取代的二唑新衍生物．初步观察了部分化合物的抗菌活性．     

Research on the fluorescence spectra of 2-(ω-biphenylylpolymethylene)-5-biphenylyl-1,3,4-oxadiazole

The fluorescence spectra of bichromophore compounds 2-(ω-biphenylylpolymethylene)-5-biphenylyl-1,3,4-oxadiazole ( 1—4 ) and its corresponding model compounds 2-methyl-5-biphenylyl-1,3,4-oxadiazole ( 5 ) and 2,5-dibiphenylyl-1,3,4-oxadiazole ( 6 ) have been determined. The formation of intra- and intermolecular excimers and exciplexes have been studied. The relationship between the molecular configuration and the formation of intra exciplex have been discussed. From the experimental results, it can be seen that when the number of the carbon atoms of the methylene bridge is odd, intra exciplex is readily formed.     

2-Phenyl-5-(4-Biphenylyl)-1,3,4-Oxadiazole and 2-(4'-tert-Butylphenyl-5)-(4'biphenylyl)-1,3,4-Oxadiazole in a Polymethyl Methacrylate Based Plastic Scintillator

The fluorescence intensity was studied for the scintillation formulation including 1,1,3-trimethyl-3-phenylindan and 2-phenyl-5-(4-biphenylyl)-1,3,4-oxadiazole, 2-(4'-tert-butylphenyl-5-(4"-biphenylyl)-1,3,4-oxadiazole, and 1,4-di(5-phenyl-2-oxazolyl)benzene. The scintillation efficiency was determined for the polymethyl methacrylate based plastic scintillator containing the above-listed compounds as luminescent additives.     

Synthesis,characterization and anticancer evaluation of 2-(naphthalen-1-ylmethyl/naphthalen-2-yloxymethyl)-1-[5-(substituted phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-1H-benzimidazole

In the present study o-phenylenediamine and naphtene-1-acetic acid/2-naphthoxyacetic acid were used as a starting material through a series of steps and 2-(naphthalen-1-ylmethyl/Naphthalen-2-yloxymethyl)-1H-benzimidazol-1-yl]acetohydrazide 5a, 5b were obtained. In the first series 1,3,4-oxadiazole derivatives have been synthesized from Schiff base of the corresponding hydrazide i.e. 2-[2-(naphthalen-1-ylmethyl)-1H-benzimidazol-1-yl]acetohydrazide 5a by using Chloramin-T. In the second series 1,3,4-oxadiazole has been synthesized from 2-{2-[(naphthalen-2-yloxy)methyl]-1Hbenzimidazol-1-yl}acetohydrazide 5b by using phosphorous oxychloride and aromatic acid. These compounds were evaluated by IR, NMR, Mass spectrometry, elemental analysis and finally in vitro anticancer evaluation was carried out by NCI 60 Cell screen at a single high dose (10–5 M) on various panel/cell lines. One compound 7c was found to be the most active on breast cancer cell line and compounds 4b and 7d were moderately active.     

6-取代苄硫基-3-(3,4,5-三甲氧基苯基)-1,2,4-三唑[3,4-b][1,3,4]噻二唑类化合物的合成与抑菌活性

以4-氨基-5-(3,4,5-三甲氧基苯基)-3-巯基-1,2,4-三唑为原料,环化得到6-巯基-3-(3,4,5-三甲氧基苯基)-1,2,4-三唑[3,4-b][1,3,4]噻二唑再与取代苄氯反应,得到9个6-取代苄硫基-3-(3,4,5-三甲氧基苯基)-1,2,4-三唑[3,4-b][1,3,4]噻二唑类衍生物3a～3i.其结构经IR,1H NMR,MS和元素分析确证.初步生物活性测试结果表明部分化合物有一定的杀菌活性.     

Synthesis and in-vitro antioxidant activities of some coumarin derivatives containing 1,2,3-triazole ring

A new green protocol was developed for the S-alkylation of 2-mercapto-1,3,4-oxadiazole by the reaction of 5-substituted-2-mercapto-1,3,4-oxadiazole with propargyl bromide in sodium bicarbonate in water. The newly synthesized 5-[(substitutedphenoxy)methyl]-2-[(prop-2-yn-1-yl)sulfanyl]-1,3,4-oxadiazole when reacted with azidomethyl coumarins underwent regioselective reaction yielding 4-(((4-((5-((substitutedphenoxy)methyl)-1,3,4-oxadiazol-2-yl)sulfanylmethyl)-1H-1,2,3-triazol-1-yl)methyl)-6-methyl)-2H-chromene-2-one or 1-((4-((5-((substitutedphenoxy)methyl)-1,3,4-oxadiazol-2-yl)sulfanylmethy)-1H-1,2,3-triazol-1-yl-)methyl)-3H-benzo[f]chromene-3-one. Structures of the newly synthesized compounds were confirmed by spectral and analytical data. The compounds were screened for their in-vitro antioxidant property.     

2-Phenyl-5-(trichloromethyl)-1,3,4-oxadiazoles,A new class of antimalarial substances

An investigation of hybrids of 2,5-dimethyl-1,3,4-oxadiazole (I) and α,α,α,α',α',α'-hexachloro-p-xylene (Hetol®) (II) as potential antimalarial agents led to the synthesis of representative 2-phenyI-5-(trichloromethyl)-1,3,4-oxadiazoles (VIa-f, VIII-X) and related trichloromethyl 1,2,4-oxadiazole, 1,3,4-oxadiazoles, and 1,3,4-thiadiazole (VII, XIII-XV). Treatment of the appropriately substituted benzoic: acid hydrazides (IVa-f) with trichloroacetic anhydride afforded the intermediate 1-benzoyl-2-(triehloroacetyl)hydrazines (Va-f) which were cyclized to the desired 5-(chlorophenyl, tolyl, or α,α,α-trifluorotolyl)-2-(trichloromethyl)-1,3,4-oxadiazoles (VIa-f) (44–66%) in situ utilizing phosphorous oxychloride. Chlorination of the 5-tolyl-2-(trichloromethyl)-1,3,4-oxadiazoles (VId-f) afforded 2-(trichloromethyl)-5-(α,α,α-trichloro-m- and p-tolyl)-1,3,4-oxadiazole (VIII and IX) and 2-(α,α,α,α',α',α'-hexachloro-3,5-xylyl)-5-(trichloromethyl)-1,3,4-oxadiazole (X) in 23–56% yield. Each of the 2-phenyl-5-(trichloromethyl)-1,3,4-oxadiazoles (VIa-f, VIII-X) was active against Plasmodium berghei in mice when administered in single 160 or 640 mg./kg. subcutaneous doses or given orally by drug-diet for 6 days at doses of 29–336 mg./kg./day. The 2-(trichloromethyl)-5-(α,α,α-trichlorotolyl)-1,3,4-oxadiazoles (VIII-X) were the most active compounds prepared and exhibited activity against P. berghei comparable with Hetol®. Structure-activity relationships are discussed.     

2,5-二[4-(2-芳基乙烯基)苯基]噁二唑的合成及发光特征

二乙烯联苯及其衍生物是一种可发射蓝光的小分子空穴型有机发光材料, 通过Wittig-Horner反应, 将电子传输型噁二唑环“嵌入”其中, 设计合成了6个2,5-二[4-(2-芳基乙烯基)苯基]-1,3,4-噁二唑化合物. 经光谱分析和元素分析等方法确认了它们的化学结构. IR和UV-vis分析数据表明标题化合物分子结构中的C＝C双键均为反式结构特征. 研究结果表明: 2,5-二[4-(2-对二甲氨基苯基乙烯基)苯基]-1,3,4-噁二唑具有良好的蓝色发光性能; 取代基对标题化合物的UV-vis吸收光谱和发光特性的影响显着.     

Synthesis and in vitro antibacterial activity of new oxoethylthio-1,3,4-oxadiazole derivatives

In the present investigation, a series of 2(4-pyridyl)-5[(aryl/heteroarylamino)-1-oxoethyl]thio-1,3,4-oxadiazole were synthesized using isonicotinohydrazide and substituted aryl/heteroaryl amines using pyridine as solvent. Newly synthesized compounds were tested for their in vitro anti-tubercular activity against Mycobacterium tuberculosis H37Rv using the BACTEC 460 radiometric system. Among the synthesized compounds, compounds 2(4-pyridyl)-5((2-nitrophenylamino)-1-oxoethyl)thio-1,3,4-oxadiazole (5e), 2(4-pyridyl)-5((4-nitrophenylamino)-1-oxoethyl)thio-1,3,4-oxadiazole (5g) and 2(4-pyridyl)-5((2-pyrrolylamino)-1-oxoethyl)thio-1,3,4-oxadiazole (5k) produced highest efficacy and exhibited >90% inhibition at a concentration of 0.0077, 0.0052 and 0.0089 μM, respectively. All the new compounds were pharmacologically evaluated for their in vitro Antimicrobial activity.